Cambridge Capital Group - Home

Recent investments completed by CCG:

Touch Type - predictive text engine for smartphones and tablet computers;
www.touchtype-online.com/
Featurespace - online analytics for gaming and financial services;
www.featurespace.co.uk
Oval Medical Technologies Ltd. - autoinjector development;
www.ovalmedical.com
Augmentra - GPS based mapping applications for mobile devices;
www.augmentra.com
Base 4 Innovation - solid state DNA sequencing;
www.base4innovation.co.uk

Pneumacare - non invasive assessment of lung function;
www.pneumacare.com

GenDrive - grid connected inverters;
www.gendrive.co.uk
Enval - aluminium reclamation from packaging waste;
www.enval.com
Ubisense Ltd – high precision, real-time location tracking of high value assets;
www.ubisense.net
Light Blue Optics - miniature video projection systems;
www.lightblueoptics.com
Metalysis - refining of high value metals and alloys;
www.metalysis.com
Nujira - efficient power amplifier technology for wireless markets;
www.nujira.com
Cambridge Temperature Concepts Ltd - fertility prediction;
www.temperatureconcepts.com
Phico Therapeutics - modified phage based therapeutic platform;
www.phicotherapeutics.co.uk

To date, our investors have made more than 40 investments in a wide range of technology sectors. Our portfolio has seen three good exits in recent years with several other strong candidates coming through to commercialisation; plus one investment now producing profitable dividends for our members and an expected AIM listing in the next few months.

Cambridge Capital Group is well integrated into the early-stage investment scene. We co-invest with the leading private and institutional technology investors, and enjoy a deal flow from a range of sources, including the members' own networks in south-east England and East Anglia.

We seek strong propositions at seed or start-up stage in high technology sectors, usually based on the physical sciences; our investors are looking for disruptive technologies with large niche or broad international markets. However, we will consider non-technology projects if they are well-differentiated with attractive markets, and come recommended from one of the members or the lead investor.